Found: 46
Select item for more details and to access through your institution.
Developmental Therapeutics Implications of Next-Generation Sequencing in Human Herpesvirus 8-Negative Castleman Disease.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Developing a Predictive Model for Clinical Outcomes of Advanced Non-Small Cell Lung Cancer Patients Treated With Nivolumab.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Recent Advances and Future Strategies for Immune-Checkpoint Inhibition in Small-Cell Lung Cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Implications of Functional Proteomics in Breast Cancer.
- Published in:
- Oncologist, 2014, v. 19, n. 4, p. 328, doi. 10.1634/theoncologist.2013-0437
- By:
- Publication type:
- Article
Safety and Efficacy of Chimeric Antigen Receptor T-Cell Therapy for Glioblastoma: A Systemic Review and Meta-Analysis.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.851877
- By:
- Publication type:
- Article
Personalized, tumor‐informed, circulating tumor DNA assay for detecting minimal residual disease in non‐small cell lung cancer patients receiving curative treatments.
- Published in:
- Thoracic Cancer, 2024, v. 15, n. 13, p. 1095, doi. 10.1111/1759-7714.15281
- By:
- Publication type:
- Article
Comparison of RECIST 1.1 and iRECIST in Patients Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis.
- Published in:
- Cancers, 2021, v. 13, n. 1, p. 120, doi. 10.3390/cancers13010120
- By:
- Publication type:
- Article
Is Personalized Medicine Here?
- Published in:
- Oncology (08909091), 2016, v. 30, n. 4, p. 293
- By:
- Publication type:
- Article
Phase I/II Trial of Carboplatin, Nab-paclitaxel, and Pembrolizumab for Advanced Non–Small Cell Lung Cancer: Hoosier Cancer Research Network LUN13-175.
- Published in:
- Oncologist, 2024, v. 29, n. 1, p. 47, doi. 10.1093/oncolo/oyad180
- By:
- Publication type:
- Article
Response to Nivolumab and Ipilimumab in Microsatellite Instability-High (MSI-H) Cervical Carcinoma with Acquired Resistance to Pembrolizumab: A Case Report and Literature Review.
- Published in:
- Oncologist, 2022, v. 27, n. 7, p. 525, doi. 10.1093/oncolo/oyac095
- By:
- Publication type:
- Article
Artificial Intelligence-based Radiomics in the Era of Immuno-oncology.
- Published in:
- Oncologist, 2022, v. 27, n. 6, p. e471, doi. 10.1093/oncolo/oyac036
- By:
- Publication type:
- Article
Clinical Implications of Circulating Tumor DNA Tumor Mutational Burden (ctDNA TMB) in Non‐Small Cell Lung Cancer.
- Published in:
- Oncologist, 2019, v. 24, n. 6, p. 820, doi. 10.1634/theoncologist.2018-0433
- By:
- Publication type:
- Article
Molecular Biomarkers of Primary and Acquired Resistance to T‐Cell‐Mediated Immunotherapy in Cancer: Landscape, Clinical Implications, and Future Directions.
- Published in:
- Oncologist, 2018, v. 23, n. 4, p. 410, doi. 10.1634/theoncologist.2017-0354
- By:
- Publication type:
- Article
Cushing's Syndrome in Adenocarcinoma of Lung Responding to Osilodrostat.
- Published in:
- Case Reports in Oncology, 2023, v. 16, n. 1, p. 130, doi. 10.1159/000527824
- By:
- Publication type:
- Article
Phase 1 study of the combination of vemurafenib, carboplatin, and paclitaxel in patients with BRAF-mutated melanoma and other advanced malignancies.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Exceptional response to chemotherapy followed by concurrent radiotherapy and immunotherapy in a male with primary retroperitoneal serous Adenocarcinoma: a case report and literature review.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Association of Tumor Mutational Burden With DNA Repair Mutations and Response to Anti-PD-1/PD-L1 Therapy in Non-Small-Cell Lung Cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Biomarkers for PD-1/PD-L1 Blockade Therapy in Non-Small-cell Lung Cancer: Is PD-L1 Expression a Good Marker for Patient Selection?
- Published in:
- 2016
- By:
- Publication type:
- journal article
Biomarkers for PD-1/PD-L1 Blockade Therapy in Non—Small-cell Lung Cancer: Is PD-Ll Expression a Good Marker for Patient Selection?
- Published in:
- Clinical Lung Cancer, 2016, v. 17, n. 5, p. 350, doi. 10.1016/j.cllc.2016.03.011
- By:
- Publication type:
- Article
Development and Validation of Insulin-like Growth Factor-1 Score to Assess Hepatic Reserve in Hepatocellular Carcinoma.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2014, v. 106, n. 5, p. 1, doi. 10.1093/jnci/dju088
- By:
- Publication type:
- Article
Mutations in DNA repair genes are associated with increased neoantigen burden and a distinct immunophenotype in lung squamous cell carcinoma.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. 1, doi. 10.1038/s41598-019-39594-4
- By:
- Publication type:
- Article
Survival Outcomes After Double-Lung Transplantation for Refractory Lung-Limited Cancers and Incidence of Post-Transplant Lung Cancer.
- Published in:
- Annals of Transplantation, 2023, v. 28, p. 1, doi. 10.12659/AOT.941301
- By:
- Publication type:
- Article
Association of the prognostic model iSEND with PD-1/L1 monotherapy outcome in non-small-cell lung cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Overcoming acquired resistance to PD-1 inhibitor with the addition of metformin in small cell lung cancer (SCLC).
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 4, p. 961, doi. 10.1007/s00262-020-02703-8
- By:
- Publication type:
- Article
Deep response to a combination of mTOR inhibitor temsirolimus and dual immunotherapy of nivolumab/ipilimumab in poorly differentiated thyroid carcinoma with PTEN mutation: a case report and literature review.
- Published in:
- Frontiers in Endocrinology, 2024, p. 1, doi. 10.3389/fendo.2024.1304188
- By:
- Publication type:
- Article
SWOG 1609 cohort 48: anti–CTLA‐4 and anti–PD‐1 for advanced gallbladder cancer.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 17, p. 2918, doi. 10.1002/cncr.35243
- By:
- Publication type:
- Article
A phase II basket trial of Dual Anti–CTLA–4 and Anti–PD–1 Blockade in Rare Tumors (DART) SWOG S1609: High‐grade neuroendocrine neoplasm cohort.
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 17, p. 3194, doi. 10.1002/cncr.33591
- By:
- Publication type:
- Article
MET Gene Copy Number Predicts Worse Overall Survival in Patients with Non-Small Cell Lung Cancer (NSCLC); A Systematic Review and Meta-Analysis.
- Published in:
- PLoS ONE, 2014, v. 9, n. 9, p. 1, doi. 10.1371/journal.pone.0107677
- By:
- Publication type:
- Article
Inhibition of Renin Angiotensin Axis May Be Associated with Reduced Risk of Developing Venous Thromboembolism in Patients with Atherosclerotic Disease.
- Published in:
- PLoS ONE, 2014, v. 9, n. 1, p. 1, doi. 10.1371/journal.pone.0087813
- By:
- Publication type:
- Article
Association between Common Allergic Symptoms and Cancer in the NHANES III Female Cohort.
- Published in:
- PLoS ONE, 2012, v. 7, n. 9, p. 1, doi. 10.1371/journal.pone.0042896
- By:
- Publication type:
- Article
Promoter DNA Methylation of Oncostatin M receptor-β as a Novel Diagnostic and Therapeutic Marker in Colon Cancer.
- Published in:
- PLoS ONE, 2009, v. 4, n. 8, p. 1, doi. 10.1371/journal.pone.0006555
- By:
- Publication type:
- Article
Genetic Polymorphisms of Estrogen Receptors α and β and the Risk of Developing Prostate Cancer.
- Published in:
- PLoS ONE, 2009, v. 4, n. 8, p. 1, doi. 10.1371/journal.pone.0006523
- By:
- Publication type:
- Article
Human AQP5 Plays a Role in the Progression of Chronic Myelogenous Leukemia (CML).
- Published in:
- PLoS ONE, 2008, v. 3, n. 7, p. 1, doi. 10.1371/journal.pone.0002594
- By:
- Publication type:
- Article
Expression of Aquaporin 5 (AQP5) Promotes Tumor Invasion in Human Non Small Cell Lung Cancer.
- Published in:
- PLoS ONE, 2008, v. 3, n. 5, p. 1, doi. 10.1371/journal.pone.0002162
- By:
- Publication type:
- Article
Nivolumab in Metastatic Adrenocortical Carcinoma: Results of a Phase 2 Trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Adverse Outcomes Associated With Use of Proton Pump Inhibitors and Clopidogrel.
- Published in:
- 2009
- By:
- Publication type:
- Letter
Folic Acid and Prevention of Colorectal Adenomas.
- Published in:
- 2007
- By:
- Publication type:
- Letter
A Comprehensive Landscape of De Novo Malignancy After Double Lung Transplantation.
- Published in:
- Transplant International, 2023, p. 1, doi. 10.3389/ti.2023.11552
- By:
- Publication type:
- Article
Definition, Incidence, and Challenges for Assessment of Hyperprogressive Disease During Cancer Treatment With Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysis.
- Published in:
- JAMA Network Open, 2021, v. 4, n. 3, p. e211136, doi. 10.1001/jamanetworkopen.2021.1136
- By:
- Publication type:
- Article
Incidence of immunotherapy‐related hyperprogressive disease (HPD) across HPD definitions and cancer types in observational studies: A systematic review and meta‐analysis.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 3, p. 1, doi. 10.1002/cam4.6970
- By:
- Publication type:
- Article
Clinical features, diagnostic challenges, and management strategies in checkpoint inhibitor-related pneumonitis.
- Published in:
- Cancer Management & Research, 2017, v. 9, p. 207, doi. 10.2147/CMAR.S136818
- By:
- Publication type:
- Article
Wnt/beta-catenin pathway: modulating anticancer immune response.
- Published in:
- Journal of Hematology & Oncology, 2017, v. 10, p. 1, doi. 10.1186/s13045-017-0471-6
- By:
- Publication type:
- Article
Phase I study of anti-epidermal growth factor receptor antibody-drug conjugate serclutamab talirine: Safety, pharmacokinetics, and antitumor activity in advanced glioblastoma.
- Published in:
- Neuro-Oncology Advances, 2023, v. 5, n. 1, p. 1, doi. 10.1093/noajnl/vdac183
- By:
- Publication type:
- Article
Spotlight on lenvatinib in the treatment of thyroid cancer: patient selection and perspectives.
- Published in:
- Drug Design, Development & Therapy, 2016, v. 10, p. 873, doi. 10.2147/DDDT.S93459
- By:
- Publication type:
- Article
Peripartum Blood Transfusions are Associated with Increased Risk of Cancer: A National Retrospective Cohort Study.
- Published in:
- Clinical Epidemiology, 2020, v. 12, p. 659, doi. 10.2147/CLEP.S244443
- By:
- Publication type:
- Article
The Association between EGFR and cMET Expression and Phosphorylation and Its Prognostic Implication in Patients with Breast Cancer.
- Published in:
- PLoS ONE, 2016, v. 11, n. 4, p. 1, doi. 10.1371/journal.pone.0152585
- By:
- Publication type:
- Article